Aid Malaria Unit Acts To Regain Credibility As Probe Continues

Ex-chief Erickson pleads guilty, and a University of Illinois scientist is ousted from his laboratory. WASHINGTON--A new team at the U.S. Agency for International Development is cleaning up the mess left by the convicted ex-chief of its malaria research program. But some scientists who are looking for a vaccine for the deadly disease say that the bad odor left by the scandal leaves them wondering where their next dollar will come from. The scarcity of funds will certainly hamper the progress

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share


Ex-chief Erickson pleads guilty, and a University of Illinois scientist is ousted from his laboratory.
WASHINGTON--A new team at the U.S. Agency for International Development is cleaning up the mess left by the convicted ex-chief of its malaria research program. But some scientists who are looking for a vaccine for the deadly disease say that the bad odor left by the scandal leaves them wondering where their next dollar will come from.

The scarcity of funds will certainly hamper the progress of finding a vaccine to protect against a disease, spread by the Anopheles mosquito, that kills 3 million people a year and may be heading to Western urban areas. But other scientists believe that the uncovering of waste and greed within the malaria research program at AID may be a blessing in disguise by deflating unrealistic expectations and providing needed oversight for the field.

The darkest chapter in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Geoffrey Brown

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo